These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 35554919

  • 1. Strengthening Biorisk Management in Research Laboratories with Security-Sensitive Biological Agents Like SARS-CoV-2.
    Phyu S, Joseph T, Goulart M.
    Methods Mol Biol; 2022; 2452():395-439. PubMed ID: 35554919
    [Abstract] [Full Text] [Related]

  • 2. Biorisk Management for SARS-CoV-2 Research in a Biosafety Level-3 Core Facility.
    Joseph T, Phyu S, Se-Thoe SY, Chu JJH.
    Methods Mol Biol; 2022; 2452():441-464. PubMed ID: 35554920
    [Abstract] [Full Text] [Related]

  • 3. Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017.
    Appelt S, Jacob D, Rohleder AM, Bråve A, Szekely Björndal Å, Di Caro A, Grunow R, Joint Action EMERGE laboratory networkThe EMERGE partners are acknowledged at the end of the article..
    Euro Surveill; 2020 Sep; 25(36):. PubMed ID: 32914748
    [Abstract] [Full Text] [Related]

  • 4. Strengthening Biorisk Management Capacities in Burkina Faso: Contribution of the Global Health Security Agenda.
    Dama E, Orelle A, Nikiema A, Mandingar PD, Naby A, Bationo GB, Kéita MS, Pierson A, Sawadogo C, Koné RG.
    Health Secur; 2022 Sep; 20(6):479-487. PubMed ID: 36399610
    [Abstract] [Full Text] [Related]

  • 5. [Biorisk Management for Clinical Diagnostic Laboratories].
    Shigematsu M.
    Rinsho Byori; 2016 Nov; 64(11):1279-1289. PubMed ID: 30695310
    [Abstract] [Full Text] [Related]

  • 6. Management System Approach for Addressing Biosafety and Biosecurity of Emerging Pathogens in a Biosafety Level-3 Core Facility.
    Joseph T.
    Appl Biosaf; 2021 Dec 01; 26(4):210-220. PubMed ID: 36034099
    [Abstract] [Full Text] [Related]

  • 7. A Cross-Sectional Survey to Assess Biorisk Management System in Research and Diagnostic Laboratories in Khyber Pakhtunkhwa, Pakistan.
    Muhammad J, Sarwar S, Khan T, Qasmi SA, Ikram A, Ahmad G, Zahid M, Durrani RH, Ahmed F.
    Front Public Health; 2021 Dec 01; 9():766162. PubMed ID: 34976925
    [Abstract] [Full Text] [Related]

  • 8. Motivating Proactive Biorisk Management.
    Greene D, Palmer MJ, Relman DA.
    Health Secur; 2023 Dec 01; 21(1):46-60. PubMed ID: 36633603
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effectiveness of international virtual training on biorisk management in the context of COVID-19.
    Qasmi SA, Standley C, Mohsin S, Sarwar S, Malik L, Aziz F.
    Front Public Health; 2022 Dec 01; 10():888097. PubMed ID: 36339241
    [Abstract] [Full Text] [Related]

  • 12. A Multilingual Tool for Standardized Laboratory Biosafety and Biosecurity Assessment and Monitoring.
    Orelle A, Nikiema A, Zakaryan A, Albetkova AA, Keita MS, Rayfield MA, Peruski LF, Pierson A.
    Health Secur; 2022 Dec 01; 20(6):488-496. PubMed ID: 36383124
    [Abstract] [Full Text] [Related]

  • 13. Implementing an Organizational Culture of Biosafety and Biosecurity in the ŞAP Institute.
    Tuncer-Göktuna P, Fontes BA, Çokçalışkan C, Asar E, Karakaya M.
    Health Secur; 2024 Aug 01; 22(4):271-280. PubMed ID: 38815143
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Biosafety and biosecurity measures: management of biosafety level 3 facilities.
    Zaki AN.
    Int J Antimicrob Agents; 2010 Nov 01; 36 Suppl 1():S70-4. PubMed ID: 20801002
    [Abstract] [Full Text] [Related]

  • 16. Understanding Biosafety and Biosecurity in Ukraine.
    Houser RS, Koblentz GD, Lentzos F.
    Health Secur; 2023 Nov 01; 21(1):70-80. PubMed ID: 36629857
    [Abstract] [Full Text] [Related]

  • 17. Harmonization of European laboratory response networks by implementing CWA 15793: use of a gap analysis and an "insider" exercise as tools.
    Sundqvist B, Bengtsson UA, Wisselink HJ, Peeters BP, van Rotterdam B, Kampert E, Bereczky S, Johan Olsson NG, Szekely Björndal A, Zini S, Allix S, Knutsson R.
    Biosecur Bioterror; 2013 Sep 01; 11 Suppl 1():S36-44. PubMed ID: 23971820
    [Abstract] [Full Text] [Related]

  • 18. National Biosafety Management System: A Combined Framework Approach Based on 15 Key Elements.
    Orelle A, Nikiema A, Zakaryan A, Albetkova AA, Rayfield MA, Peruski LF, Pierson A, Kachuwaire O.
    Front Public Health; 2021 Sep 01; 9():609107. PubMed ID: 34368035
    [Abstract] [Full Text] [Related]

  • 19. Implementation of Active Learning Approach to Teach Biorisk Management and Dual-Use Research of Concern in Egypt.
    Elhadidy M, El-Tholoth M, Brocard AS.
    Appl Biosaf; 2019 Jun 01; 24(2):100-110. PubMed ID: 36033939
    [Abstract] [Full Text] [Related]

  • 20. Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations.
    Lippi G, Adeli K, Ferrari M, Horvath AR, Koch D, Sethi S, Wang CB.
    Clin Chem Lab Med; 2020 Jun 25; 58(7):1053-1062. PubMed ID: 32396137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.